He has published more than 170 original articles, reviews and book chapters in the fields of nephrology, dialysis and transplantation. Advisor/Consultant: Merck (Schering Plough); Novartis; Speaker: AstraZeneca; Bristol-Myers Squibb; Novartis Shanthi Mendis, MBBS, MD, FRCP, FACC, is Senior Advisor for Cardiovascular Diseases and Coordinator, Chronic Disease Prevention and Management at the World Health Organization (WHO) in Geneva, Switzerland. Prior to taking up the position in WHO, she was Professor of Medicine at Peradeniya Medical School in Sri Lanka from 1991 2000. As a specialist in cardiology and public health with expertise in policy development, she has written extensively on the prevention and management of CVD in a global context. In particular, she has advocated for the development of national policies and strategies to combat non-communicable diseases which strike disproportionately in low- and middle-income countries. Dr Mendis reported no relevant financial relationships Suzanne Oparil, MD, is Professor of Medicine, Professor of Cell, Developmental and Integrative Biology, and Physiology & Biophysics, and Director of the Vascular Biology and Hypertension Program of the Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham. She earned her medical degree at Columbia University College of Physicians and Surgeons, New York and completed her medical residency at Columbia Presbyterian Hospital and cardiology fellowship at Massachusetts General Hospital. Dr Oparil is Past President of the American Heart Association (AHA) and American Society of Hypertension, and a member of numerous editorial boards, societies and important advisory positions with the NIH (Co-Chair, JNC 8). She has published over 700 journal articles, books, and book chapters on topics in clinical cardiology, vascular biology and hypertension. 